Similar Items: Niraparib in pancreatic cancer with germline or somatic DNA damage repair (DDR) gene alterations (BRCA and beyond): a phase II study (NIRA-PANC)
- Finding novel vulnerabilities of hypomorphic BRCA1 alleles
- Deciphering transcriptional plasticity in pancreatic ductal adenocarcinoma reveals alterations in sensory neuron innervation
- Pathogenic germline variants identified in pNEN patients during genetic testing
- Divergent biology and outcomes of somatic transformations in germ cell tumors
- Women’s health across the reproductive lifespan in women with germline TP53 pathogenic variants: a clinical perspective
- Advancing Germline Genetic Testing for Breast Cancer in Resource-Restricted Settings: Evidence, Barriers, and a Practical Roadmap for Implementation